| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 09/24/2009 | US20090239897 Novel compounds |
| 09/24/2009 | US20090239841 Diaryl Ureas as CB1 Antagonists |
| 09/24/2009 | CA2718551A1 Substituted sulfonamide derivatives |
| 09/23/2009 | EP2102162A1 Phenylic derivatives and use thereof as drugs |
| 09/23/2009 | CN101541753A 2-Aminoquinolines as 5-HT(5A) receptor antagonists |
| 09/23/2009 | CN101541752A 抗菌的喹啉衍生物 Antibacterial quinoline derivatives |
| 09/23/2009 | CN101541751A Quinoline compounds |
| 09/23/2009 | CN101538254A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme |
| 09/23/2009 | CN101538252A Novel preparation method and intermediate for aripiprazole |
| 09/22/2009 | US7592457 3-aryl-3-methyl-quinoline-2, 4-diones, preparation method thereof, and pharmaceutical composition containing the same |
| 09/22/2009 | US7592456 Arylsulfonylnaphthalene derivatives as 5HT2A antagonists |
| 09/22/2009 | US7592358 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
| 09/22/2009 | US7592346 e.g. 3-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-oxazolidin-2-one; serotonin receptor antagonist and inverse agonists, agonists or partial agonists, serotonin reuptake inhibitor; antidepressant, anxiolytic agent |
| 09/22/2009 | CA2399451C Tyrosine derivatives with anti-leukotriene activity |
| 09/22/2009 | CA2209640C Cycloalkano-pyridines |
| 09/17/2009 | WO2009113087A1 Montelukast benzhydryl piperazine salts and process for preparation thereof |
| 09/17/2009 | WO2009112854A1 Compounds having electroluminescent or electron transport properties |
| 09/17/2009 | WO2009112677A2 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009112568A1 Novel quinolinylamide derivatives useful as modulators of dopamine and serotonin receptors |
| 09/17/2009 | WO2009112395A1 2-aminoquinolines as 5-ht5a receptor antagonists |
| 09/17/2009 | WO2009111998A2 Specific impurities of montelukast |
| 09/17/2009 | WO2007148191A3 An improved process for the preparation of aripiprazole |
| 09/17/2009 | US20090233927 2-aminoquinolines |
| 09/17/2009 | US20090232889 Crystalline salts of quinoline compounds and methods for preparing them |
| 09/17/2009 | CA2716907A1 2-aminoquinolines as 5-ht5a receptor antagonists |
| 09/17/2009 | CA2712914A1 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 09/16/2009 | EP2100881A1 Pyrimidyl- or pyridinylaminobenzoic acid derivatives |
| 09/16/2009 | EP2100876A2 New compounds for the inhibition of rotamases and use thereof |
| 09/16/2009 | EP2099763A1 2-aminoquinolines as 5-ht(5a) receptor antagonists |
| 09/16/2009 | EP2099762A1 Antibacterial quinoline derivatives |
| 09/16/2009 | EP2099761A2 Antibacterial quinoline derivatives |
| 09/16/2009 | EP2099760A1 Antibacterial quinoline derivatives |
| 09/16/2009 | EP2099759A1 Antibacterial quinoline derivatives |
| 09/16/2009 | EP2099758A1 Antibacterial quinoline derivatives |
| 09/16/2009 | EP1564210B1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
| 09/16/2009 | EP1411046B1 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
| 09/16/2009 | EP1363629B1 Kappa opioid receptor ligands |
| 09/16/2009 | CN101535267A Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 09/16/2009 | CN101535266A Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 09/16/2009 | CN101531633A Purification method of quinaldine |
| 09/16/2009 | CN101531599A Green electroluminescent compounds and organic electroluminescent device using the same |
| 09/16/2009 | CN101531565A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 09/16/2009 | CN100540534C N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides |
| 09/15/2009 | US7589209 8-hydroxyquinoline tripodal metal ion probes |
| 09/15/2009 | US7589208 Solid dosage of a salt of a 3-quinoline-carboxamide derivative that is storage stable for three years; e.g. lithium or calcium salt of laquinimod |
| 09/15/2009 | US7589128 Process for preparation of amorphous form of a drug |
| 09/15/2009 | CA2464289C Heterocyclic retinoid compounds |
| 09/11/2009 | WO2009110985A2 Amide compounds, compositions and uses thereof |
| 09/11/2009 | WO2009110542A1 Anilide compound and use thereof |
| 09/11/2009 | WO2009109502A1 2-aminoquinolines |
| 09/11/2009 | WO2009109493A2 2-aminoquinolines |
| 09/11/2009 | WO2009109491A1 2-aminoquinoline derivatives |
| 09/11/2009 | WO2009015067A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 09/11/2009 | CA2717453A1 2-aminoquinolines |
| 09/11/2009 | CA2715842A1 2-aminoquinoline derivatives |
| 09/11/2009 | CA2715835A1 Amide compounds, compositions and uses thereof |
| 09/11/2009 | CA2711247A1 2-aminoquinolines |
| 09/10/2009 | US20090227628 2-aminoquinolines |
| 09/10/2009 | US20090227626 Novel polyquinoline derivatives and therapeutic use thereof |
| 09/10/2009 | US20090227625 Cxcr2 inhibitors |
| 09/10/2009 | US20090227609 Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents |
| 09/10/2009 | US20090227585 Substituted n-heterocycle derivatives and methods of their use |
| 09/10/2009 | US20090227584 2-aminoquinoline derivatives |
| 09/10/2009 | US20090227583 2-aminoquinolines |
| 09/10/2009 | US20090227582 Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors |
| 09/10/2009 | US20090227571 Androgen Receptor Modulator Compounds and Methods |
| 09/10/2009 | US20090227570 2-aminoquinolines |
| 09/10/2009 | US20090227547 Novel salt form of a Beta2-adrenergic agonist quinolin-2-one derivative |
| 09/10/2009 | US20090226377 Novel sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors |
| 09/09/2009 | EP2097373A1 Sulfonamide derivatives as liver carnitine palmitoyl transferase (l-cptl ) |
| 09/09/2009 | EP1809284A4 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 09/09/2009 | EP1567477B1 Substituted amino phenylacetic acids, derivatives thereof, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 09/09/2009 | CN101528702A Quinoline compounds and methods of use |
| 09/09/2009 | CN101525354A Novel organic electroluminescent compound exhibiting high luminous efficiency, and organic electroluminescent device using the same |
| 09/09/2009 | CN101525316A Quinoline derivatives, preparation method and applications thereof |
| 09/09/2009 | CN101525315A Chemical process for the extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole |
| 09/09/2009 | CN100537541C Improved process for preparing rebamipide |
| 09/09/2009 | CN100537540C Novel process for preparing 3-fluoroquinolines |
| 09/09/2009 | CN100537534C Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 09/08/2009 | US7585976 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
| 09/08/2009 | US7585863 Antitumor agents; such as (2-(4-(7-Chloro-2-quinoxalinyl)oxy)propionylamino ethansulfonic acid; {2-{4-(7-Chloro-quinoxalin-2-yloxy)-phenoxy}propionyl amino}acetic acid |
| 09/08/2009 | US7585845 Using protease inhibitor |
| 09/08/2009 | CA2458929C Process for preparing aripiprazole |
| 09/08/2009 | CA2314339C N-benzyl-3-indenylacetamide derivatives for treating neoplasia |
| 09/08/2009 | CA2213466C Inhibitors of microsomal triglyceride transfer protein and method |
| 09/03/2009 | WO2009106586A1 Quinolines as inhibitors of farnesyl pyrophosphate synthase |
| 09/03/2009 | WO2009106351A1 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the b2 adrenergic receptor |
| 09/03/2009 | WO2009049791A3 Radiolabeled nk3 receptor antagonist |
| 09/03/2009 | US20090221817 Triethylamine was added dropwise to a solution of 2-methylpropane-2-sulfinyl chloride and methyl trans-4-amino-1-cyclohexane carboxylate p-toluenesulfonate in tetrahydrofuran solvent to obtain Methyl trans-4-(2-methylpropane-2-sulfonylamino)cyclohexanecarboxylate; hydrolysis; oxidation; intermediates |
| 09/03/2009 | US20090221636 Argatroban formulations and methods for making and using same |
| 09/03/2009 | US20090221635 Quinolinyl and benzothiazolyl modulators |
| 09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
| 09/03/2009 | US20090218039 Coloring composition, thermal transfer recording ink sheet, thermal transfer recording method, color toner, inkjet ink, color filter, and dye compound |
| 09/03/2009 | CA2717011A1 Quinolines as inhibitors of farnesyl pyrophosphate synthase |
| 09/03/2009 | CA2716397A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor |
| 09/02/2009 | EP2096109A1 Carboxylic acid derivative |
| 09/02/2009 | EP2096105A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor |
| 09/02/2009 | EP2096104A1 Organic diamines as mGluR7 modulators |
| 09/02/2009 | EP2094665A2 Preparation of montelukast and its salts |